Lifetime prevalence of psychotic and bipolar I disorders in a general population.
about
Psychedelics and mental health: a population studyAntiglucocorticoid and related treatments for psychosisChlorpromazine versus penfluridol for schizophreniaChlorpromazine versus clotiapine for schizophreniaCollaborative care approaches for people with severe mental illnessCollaborative care approaches for people with severe mental illnessAntiglucocorticoid and related treatments for psychosisReplication of association between working memory and Reelin, a potential modifier gene in schizophreniaEfficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysisCircuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaAge of onset of mental disorders: a review of recent literatureThe mental health and wellbeing of first generation migrants: a systematic-narrative review of reviewsA Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain StimulationA critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorderAn evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature reviewGender differences in individuals at high-risk of psychosis: a comprehensive literature reviewThe neuroimmunology of schizophreniaAt risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical riskObesity and psychotic disorders: uncovering common mechanisms through metabolomicsSulfur Mustard Effects on Mental Health and Quality-of-Life: A ReviewSearch for missing schizophrenia genes will require a new developmental neurogenomic perspectivePsychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gapOlfactory function in psychotic disorders: Insights from neuroimaging studiesReplication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia familiesPsychopathology in multiple sclerosis: diagnosis, prevalence and treatmentHomozygous Deletion of Glutathione Peroxidase 1 and Aldehyde Dehydrogenase 1a1 Genes Is Not Associated with Schizophrenia-Like Behavior in MiceThe Psychosis Recent Onset GRoningen Survey (PROGR-S): defining dimensions and improving outcomes in early psychosisPsychotic Experiences and Working Memory: A Population-Based Study Using Signal-Detection AnalysisAdult psychotic symptoms, their associated risk factors and changes in prevalence in men and women over a decade in a poor rural district of KenyaEvolutionary conservation in genes underlying human psychiatric disordersDelusional disorders--are they simply paranoid schizophrenia?"The Opposite of Treatment": A qualitative study of how patients diagnosed with psychosis experience music therapy.Schizophrenia and 1957 pandemic of influenza: meta-analysis.Molecular substrates of schizophrenia: homeostatic signaling to connectivityExploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis.Reward processing in autism: a thematic series.NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.Brain structural changes and neuropsychological impairments in male polydipsic schizophrenia.Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis
P2860
Q21089784-6072F0B6-A8D4-43E3-B6F9-2C3C7273CE4FQ24186594-7BB3F637-0482-4149-B82D-8B7B4AD44F76Q24188120-80C6AEED-AFF7-4C2E-8030-8D4B9D9FE79EQ24188238-1D91F605-CBC6-45E4-A445-BB1FC0112FF0Q24202558-75128DD9-06C0-4C52-BEC6-362CCC3D7247Q24203981-FC3D5126-66D6-40CB-A6B1-B23B5CF69467Q24243495-7C7453E6-F6F4-4813-B325-BF652E05957FQ24606481-70024660-E52C-4CBF-8EBE-F51857513952Q24606868-6935F0CA-999B-4060-B706-8C831D2CCDB2Q24646206-7E02B282-1D0A-41BC-9080-DF5E6291CD82Q24669789-D1B6A834-6CD0-4A9B-B88D-AF8B3EF37D9BQ26739002-A69C9C28-6AE6-4505-A24F-62A979401D61Q26749677-BFFC5A49-E90A-44F4-AAE9-822E68040793Q26766541-06C190CE-A1A7-40D2-BF39-2F0B3FAEC9F8Q26799270-6872B99F-7BA2-4A3E-8861-DEBA75B4579EQ26826971-38C13E9A-E056-4A66-8544-8AC5DA9F5814Q26859392-8E146FC0-CD19-4757-B277-98ACDCC08F9FQ27002449-B4CD8BF4-F3E0-44A3-9CD6-BABA36BDBBA2Q27011617-B22AF685-26A5-47C1-8176-1EF0371096C3Q27016116-7E92E038-A864-4C5E-99AF-9F5B87C2907EQ27024141-153086F7-1F50-4847-9D43-38D1050A2A55Q28081111-92F2D8AA-398E-4BF7-965C-CFBE5D3BD56CQ28083868-E9782107-29C8-4415-A2E0-CCB2F845B51CQ28239852-9E9AC0C6-9394-49C8-98DB-145783B66627Q28301691-CFDC06E7-424F-4DCF-A98D-7FB44776518CQ28395280-4DD8EDD8-C1AA-4154-9457-F0852C4CDEC3Q28545094-FD3A4480-7388-4646-B8FF-C3F06B026B8AQ28551625-ED6FBE35-1A7E-4AE6-A25D-078DFC248B2FQ28645976-1F3E0829-1A24-427C-B280-4FE285860AEAQ28657468-865CD842-8BBA-4471-877C-BAEE74DFC746Q30318537-21107DC9-C051-4378-9030-170F5AFBB1AEQ30376461-DC9391BA-9A83-4C77-AA81-5B95F665254EQ30383157-5581BF22-D007-4787-A367-F59A801D499EQ30383611-AFBFEF44-CC24-4850-B78E-5C0033C44826Q30458875-DFEA4A0C-A94C-418C-B148-477CD08574BCQ30462673-5961E5F8-E1E5-4FDD-89ED-A1BA24BFD23BQ30465008-435555AC-AC28-42D5-8D7C-64C127B58504Q30479407-C3078221-84A2-482A-AB44-A1A3682CD153Q30578538-13170CFA-5295-4241-AF88-967734748A1CQ30723937-D1F8FDAE-DD6A-4852-BFF9-05294B6EBFF4
P2860
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@ast
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@en
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@nl
type
label
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@ast
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@en
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@nl
prefLabel
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@ast
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@en
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@nl
P2093
P50
P356
P1433
P1476
Lifetime prevalence of psychotic and bipolar I disorders in a general population.
@en
P2093
Erkki Isometsä
Jukka Hintikka
Kimmo Kuoppasalmi
Sami Pirkola
Samuli I Saarni
Tommi Härkänen
Tuula Kieseppä
P356
10.1001/ARCHPSYC.64.1.19
P407
P50
P577
2007-01-01T00:00:00Z